Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study

  • Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Saki N, Karandish M, Cheraghian B, Heybar H, Hashemi SJ, Azhdari M. Prevalence of cardiovascular diseases and associated factors among adults from southwest Iran: baseline data from Hoveyzeh Cohort Study. BMC Cardiovasc Disord. 2022;22(1):1–10.

    Article 

    Google Scholar 

  • Ramezankhani A, Azizi F, Hadaegh F. Lifetime risk of cardiovascular disease stratified by traditional risk factors: findings from the cohort of Tehran lipid and glucose study. Hellenic J Cardiol. 2023;73:36–46.

    Article 
    PubMed 

    Google Scholar 

  • Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204–10.

    PubMed 

    Google Scholar 

  • Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157–72.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wang Y-N, Ma S-X, Chen Y-Y, Chen L, Liu B-L, Liu Q-Q, et al. Chronic kidney disease: biomarker diagnosis to therapeutic targets. Clin Chim Acta. 2019;499:54–63.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Bjornstad P, Karger AB, Maahs DM. Measured GFR in routine clinical practice—the promise of dried blood spots. Adv Chronic Kidney Dis. 2018;25(1):76–83.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–31.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Heerspink HJL, Tighiouart H, Sang Y, Ballew S, Mondal H, Matsushita K, et al. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials. Am J Kidney Dis. 2014;64(6):860–6.

    Article 

    Google Scholar 

  • Orlandi PF, Xie D, Yang W, Cohen JB, Deo R, Ricardo AC, et al. Slope of kidney function and its association with longitudinal mortality and cardiovascular disease among individuals with CKD. J Am Soc Nephrol. 2020;31(12):2912–23.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, et al. Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data. J Am Soc Nephrol. 2019;30(9):1746–55.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Oshima M, Jun M, Ohkuma T, Toyama T, Wada T, Cooper ME, et al. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. Diabetologia. 2019;62(11):1988–97.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action. World J Diabetes. 2021;12(9):1401.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ramezankhani A, Azizi F, Hadaegh F. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study. Cardiovasc Diabetol. 2022;21(1):227.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC et al. Management of patients with diabetes and CKD: áconclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference. Kidney international. 2016;90(6):1175-83.

  • Li H, Lu W, Wang A, Jiang H, Lyu J. Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: estimates from global burden of Disease 2017. J Diabetes Invest. 2021;12(3):346–56.

    Article 

    Google Scholar 

  • Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hubbard D, Colantonio LD, Rosenson RS, Brown TM, Jackson EA, Huang L, et al. Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease. Cardiovasc Diabetol. 2021;20(1):58.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):1–15.

    Article 

    Google Scholar 

  • Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an iranian urban population: Tehran lipid and glucose study (phase 1). Sozial-und präventivmedizin. 2002;47:408–26.

    Article 
    PubMed 

    Google Scholar 

  • Sardarinia M, Asgari S, Hizomi Arani R, Eskandari F, Azizi F, Khalili D, et al. Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: more than a decade follow up in the Tehran lipids and glucose study. J Diabetes Invest. 2022;13(2):317–27.

    Article 
    CAS 

    Google Scholar 

  • Nelson RG, Grams ME, Ballew SH, Sang Y, Azizi F, Chadban SJ, et al. Development of risk prediction equations for incident chronic kidney disease. JAMA. 2019;322(21):2104–14.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–72.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH et al. /ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2018;71(19):e127-e248.

  • Khalili D, Azizi F, Asgari S, Zadeh-Vakili A, Momenan AA, Ghanbarian A et al. Outcomes of a longitudinal population-based cohort study and pragmatic community trial: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metabolism. 2018;16(4 Suppl).

  • Verbeke G, Molenberghs G, Rizopoulos D. Random effects models for longitudinal data. Longitudinal research with latent variables: Springer; 2010. pp. 37–96.

    Google Scholar 

  • Janmaat CJ, van Diepen M, Tsonaka R, Jager KJ, Zoccali C, Dekker FW. Pitfalls of linear regression for estimating slopes over time and how to avoid them by using linear mixed-effects models. Nephrol Dialysis Transplantation. 2019;34(4):561–6.

    Article 

    Google Scholar 

  • Carracedo J, Alique M, Vida C, Bodega G, Ceprián N, Morales E, et al. Mechanisms of Cardiovascular Disorders in patients with chronic kidney disease: a process related to Accelerated Senescence. Front cell Dev Biology. 2020;8:185.

    Article 

    Google Scholar 

  • Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1–3):84–92.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Rajagopal K, Karthikeyan A. Complex dynamics in a fractional order nephron pressure and flow regulation model. Bio Syst. 2023;230:104931.

    CAS 

    Google Scholar 

  • Dube P, DeRiso A, Patel M, Battepati D, Khatib-Shahidi B, Sharma H et al. Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall. 2021;9(4).

  • Warren B, Rebholz CM. Diabetes and trajectories of estimated glomerular filtration rate: a prospective cohort analysis of the atherosclerosis risk in Communities Study. Diabetes Care. 2018;41(8):1646–53.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28(4):1023–39.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang Y, Xu G. Update on pathogenesis of glomerular hyperfiltration in Early Diabetic kidney disease. Front Endocrinol. 2022;13:872918.

    Article 

    Google Scholar 

  • Yau K, Dharia A, Alrowiyti I, Cherney DZI. Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations. Kidney Int Rep. 2022;7(7):1463–76.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Triozzi JL, Parker Gregg L, Virani SS, Navaneethan SD. Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Research & Care. 2021;9(1).

  • Moazzeni SS, Hizomi Arani R, Deravi N, Hasheminia M, Khalili D, Azizi F, et al. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran lipid and glucose study. Cardiovasc Diabetol. 2021;20(1):141.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Melsom T, Nair V, Schei J, Mariani L, Stefansson VTN, Harder JL, et al. Correlation between baseline GFR and subsequent change in GFR in norwegian adults without diabetes and in Pima Indians. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2019;73(6):777–85.

    Article 

    Google Scholar 

  • Ko GJ, Rhee CM, Kalantar-Zadeh K, Joshi S. The Effects of high-protein diets on kidney health and longevity. J Am Soc Nephrol. 2020;31(8):1667–79.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Borrelli S, Provenzano M. Sodium intake and chronic kidney disease. Int J Mol Sci. 2020;21(13).

  • Turin TC, Jun M, James MT, Tonelli M, Coresh J, Manns BJ, et al. Magnitude of rate of change in kidney function and future risk of cardiovascular events. Int J Cardiol. 2016;202:657–65.

    Article 
    PubMed 

    Google Scholar 

  • Ragot S, Saulnier PJ, Velho G, Gand E, de Hauteclocque A, Slaoui Y, et al. Dynamic changes in renal function are Associated with Major Cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2016;39(7):1259–66.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Nagai K, Yamagata K, Ohkubo R, Saito C, Asahi K, Iseki K, et al. Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria. Nephrology. 2014;19(9):574–80.

    Article 
    PubMed 

    Google Scholar 

  • Guo Y, Cui L, Ye P, Li J, Wu S, Luo Y. Change of kidney function is associated with all-cause mortality and cardiovascular diseases: results from the kailuan study. J Am Heart Association. 2018;7(21):e010596.

    Article 
    CAS 

    Google Scholar 

  • Van Pottelbergh G, Mamouris P, Opdeweegh N, Vaes B, Goderis G, Van Den Akker M. Is there a correlation between an eGFR slope measured over a 5-year period and incident cardiovascular events in the following 5 years among a flemish general practice population: a retrospective cohort study. BMJ open. 2018;8(11):e023594.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Suchy-Dicey AM, Zhang Y, McPherson S, Tuttle KR, Howard BV, Umans J, et al. Glomerular filtration function decline, mortality, and cardiovascular events: data from the strong heart study. Kidney360. 2021;2(1):71–8.

    Article 
    PubMed 

    Google Scholar 

  • van Rijn MHC, Metzger M, Flamant M, Houillier P, Haymann JP, van den Brand J, et al. Performance of creatinine-based equations for estimating glomerular filtration rate changes over time. Nephrol Dial Transplant. 2020;35(5):819–27.

    Article 
    PubMed 

    Google Scholar 

  • Gaspari F, Ruggenenti P, Porrini E, Motterlini N, Cannata A, Carrara F, et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int. 2013;84(1):164–73.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes. BMC Nephrol. 2020;21(1):167.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, et al. Change in Albuminuria and GFR as End points for clinical trials in early stages of CKD: A Scientific Workshop Sponsored by the national kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am J Kidney Dis. 2020;75(1):84–104.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Leave a Reply

    Your email address will not be published. Required fields are marked *